We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRGP icon
826
Targa Resources
TRGP
$57.4B
– –
-20,694
Closed -$1.39M
TRI icon
827
Thomson Reuters
TRI
$42.7B
– –
-156,910
Closed -$19.8M
TTC icon
828
Toro Company
TTC
$9.03B
– –
-13,550
Closed -$1.39M
TU icon
829
Telus
TU
$16.3B
– –
-361,735
Closed -$6.6M
UL icon
830
Unilever
UL
$132B
– –
-26,323
Closed -$1.42M
VERV
831
DELISTED
Verve Therapeutics
VERV
– –
-25,547
Closed -$339K
VFC icon
832
VF Corp
VFC
$6.71B
– –
-56,370
Closed -$1.19M
VREX icon
833
Varex Imaging
VREX
$463M
– –
-25,735
Closed -$431K
VRNS icon
834
Varonis Systems
VRNS
$5.35B
– –
-779,793
Closed -$18.7M
WBS icon
835
Webster Financial
WBS
$12.5B
– –
-9,802
Closed -$356K
WK icon
836
Workiva
WK
$3.12B
– –
-18,305
Closed -$1.73M
YELP icon
837
Yelp
YELP
$1.46B
– –
-15,843
Closed -$448K
YETI icon
838
Yeti Holdings
YETI
$3.87B
– –
-436,999
Closed -$16.1M
ZD icon
839
Ziff Davis
ZD
$1.93B
– –
-6,135
Closed -$441K
ZIP icon
840
ZipRecruiter
ZIP
$344M
– –
-29,854
Closed -$438K
ZWS icon
841
Zurn Elkay Water Solutions
ZWS
$8.16B
– –
-220,652
Closed -$4.34M
GAP
842
The Gap Inc
GAP
$7.04B
– –
-71,404
Closed -$660K
PVLA
843
Palvella Therapeutics
PVLA
$2.04B
– –
-4,398
Closed -$316K
ONC
844
BeOne Medicines Ltd
ONC
$33.9B
– –
-6,033
Closed -$1.2M
PDCO
845
DELISTED
Patterson Companies, Inc.
PDCO
– –
-17,445
Closed -$430K
NVRO
846
DELISTED
NEVRO CORP.
NVRO
– –
-14,996
Closed -$499K
NARI
847
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-7,713
Closed -$438K
LSXMK
848
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
– –
-33,405
Closed -$667K
LSXMA
849
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
– –
-28,214
Closed -$536K
MOR
850
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
-58,169
Closed -$212K
31 32 33
34
35

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.